Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China flag China · Delayed Price · Currency is CNY
5.76
-0.10 (-1.71%)
Nov 18, 2026, 3:00 PM CST

SHA:600613 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
557.91594.09779.39715.28656.49493.8
Short-Term Investments
-80.75----
Trading Asset Securities
198.04110.420.8720.9--
Cash & Short-Term Investments
755.95785.24800.27736.17656.49493.8
Cash Growth
-8.01%-1.88%8.71%12.14%32.95%2.56%
Accounts Receivable
502642.7529.62750.25813.82675.75
Other Receivables
9.838.94.89.7411.0920.38
Receivables
511.83651.6534.42759.99824.91696.12
Inventory
211.27197.5228.34242.86218.82205.13
Other Current Assets
16.9519.5732.8833.2369.6750.8
Total Current Assets
1,4961,6541,5961,7721,7701,446
Property, Plant & Equipment
975.71,0311,0541,0521,1001,167
Long-Term Investments
74.1786.1987.0274.1467.3383.08
Goodwill
243.85243.85243.85243.85299.06299.06
Other Intangible Assets
91.0793.396.6595.298.91104.81
Long-Term Deferred Tax Assets
26.7225.2223.1723.4436.0228.83
Long-Term Deferred Charges
1.822.331.641.631.852.3
Other Long-Term Assets
10.29.4613.2116.6612.8518.13
Total Assets
2,9203,1453,1163,2793,3863,149

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
219241.9223.85249.85186.8188.31
Accrued Expenses
14.8834.3829.2131.9849.7625.89
Short-Term Debt
4961.9127.031821.082.72
Current Portion of Long-Term Debt
8.338.2840.7436.9235.6836
Current Portion of Leases
-8.399.3311.028.6615.74
Current Income Taxes Payable
25.544.345.112.247.910.04
Current Unearned Revenue
29.7135.5835.429.6782.8345.06
Other Current Liabilities
168.42196.04160.21306.36381.62156.04
Total Current Liabilities
514.85620.82530.88686.04774.34479.81
Long-Term Debt
-88.56129.58170.1207.7242.9
Long-Term Leases
4.912.3510.4517.0312.4814.92
Long-Term Unearned Revenue
8.158.841.651.261.533.02
Long-Term Deferred Tax Liabilities
14.1917.0216.4514.3418.2415.81
Total Liabilities
542.1747.59689.01888.771,014756.45

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
534.07534.07534.07534.07534.07534.07
Additional Paid-In Capital
968.99968.99968.99968.99968.99968.99
Retained Earnings
770.7787.37829.24811.25807.79813.1
Comprehensive Income & Other
20.6129.930.7421.0716.2628.12
Total Common Equity
2,2942,3202,3632,3352,3272,344
Minority Interest
83.0677.263.7755.1844.7348.23
Shareholders' Equity
2,3772,3982,4272,3912,3722,393
Total Liabilities & Equity
2,9203,1453,1163,2793,3863,149

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
62.2209.49217.13253.07285.61312.28
Net Cash (Debt)
693.75575.75583.14483.11370.88181.52
Net Cash Growth
10.52%-1.27%20.71%30.26%104.32%-4.07%
Net Cash Per Share
1.351.051.060.930.690.34
Filing Date Shares Outstanding
534.07534.07534.07534.07534.07534.07
Total Common Shares Outstanding
534.07534.07534.07534.07534.07534.07
Working Capital
981.151,0331,0651,086995.55966.05
Book Value Per Share
4.304.344.424.374.364.39
Tangible Book Value
1,9591,9832,0231,9961,9291,940
Tangible Book Value Per Share
3.673.713.793.743.613.63
Buildings
-1,0911,0021,0011,001978.49
Machinery
-709.05651.9651.59643.1607.56
Construction In Progress
-41.3141.2563.9553.8358.26